Trial Profile
A Randomised, Double-blind, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of Sulforadex® in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Jan 2014
Price :
$35
*
At a glance
- Drugs Sulforafan (Primary)
- Indications Cancer; Prostate cancer
- Focus Adverse reactions
- Sponsors Evgen Pharma
- 21 Jan 2014 New trial record